Sana Biotechnology
SANA
SANA
132 hedge funds and large institutions have $511M invested in Sana Biotechnology in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 27
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
84% less call options, than puts
Call options by funds: $303K | Put options by funds: $1.94M
Holders
132
Holding in Top 10
2
Calls
$303K
Puts
$1.94M
Top Buyers
| 1 | +$6.87M | |
| 2 | +$5.3M | |
| 3 | +$3.57M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$2.61M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.57M |
Top Sellers
| 1 | -$14M | |
| 2 | -$6.33M | |
| 3 | -$5.54M | |
| 4 |
CC
Casdin Capital
New York
|
-$2.9M |
| 5 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$2.66M |